Literature DB >> 6470328

Comparison of programmed electrical stimulation and ambulatory electrocardiographic (Holter) monitoring in the management of ventricular tachycardia and ventricular fibrillation.

E V Platia, P R Reid.   

Abstract

Forty-four patients with primary ventricular fibrillation or recurrent ventricular tachycardia were stabilized on an antiarrhythmic drug regimen before electrophysiologic study and 24 to 72 hours of ambulatory electrocardiographic monitoring were performed. The long-term predictive value of these two tests was then compared retrospectively for a 12 to 32 month (mean 18) follow-up period, during which all patients continued receiving the same antiarrhythmic drug regimen. Electrophysiologic testing induced ventricular tachycardia (greater than or equal to 3 beats) in 26 patients; 23 had a poor clinical outcome (positive predictive value 88%), defined as sudden death or sustained ventricular tachycardia. In 18 patients with a negative electrophysiologic test, only 1 had a poor clinical outcome (negative predictive value 94%). Ambulatory electrocardiographic monitoring accurately predicted outcome in 7 of 10 patients with a positive recording (positive predictive value 70%), defined as three or more consecutive ventricular extrasystoles, and in 17 of 34 patients with negative ambulatory monitor recordings (negative predictive value 50%). The long-term predictive accuracy of the electrophysiologic study was significantly higher than that of the ambulatory electrocardiographic monitor (p less than 0.001). Electrophysiologic studies offer advantages over ambulatory electrocardiographic monitoring in this high risk patient group, providing a high degree of accuracy in predicting the long-term clinical response to antiarrhythmic drugs for at least 18 months.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6470328     DOI: 10.1016/s0735-1097(84)80092-3

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  6 in total

Review 1.  Risk-benefit assessment of antiarrhythmic drugs. An epidemiological perspective.

Authors:  L Friedman; E Schron; S Yusuf
Journal:  Drug Saf       Date:  1991 Sep-Oct       Impact factor: 5.606

Review 2.  Programmed stimulation in the evaluation of life-threatening or potentially life-threatening ventricular arrhythmias.

Authors:  C Gottlieb; M E Josephson
Journal:  Cardiovasc Drugs Ther       Date:  1987-08       Impact factor: 3.727

3.  Holter monitoring versus programmed ventricular stimulation.

Authors:  M Borggrefe; G Breithardt
Journal:  Cardiovasc Drugs Ther       Date:  1990-06       Impact factor: 3.727

Review 4.  Practical optimisation of antiarrhythmic drug therapy using pharmacokinetic principles.

Authors:  J L Bauman; M D Schoen; T J Hoon
Journal:  Clin Pharmacokinet       Date:  1991-02       Impact factor: 6.447

5.  Efficacy of phenytoin in suppressing inducible ventricular tachyarrhythmias.

Authors:  R N Fogoros; S B Fiedler; J J Elson
Journal:  Cardiovasc Drugs Ther       Date:  1988-07       Impact factor: 3.727

6.  A comparison of sotalol and procainamide in symptomatic ventricular tachycardia.

Authors:  L J Jordaens; F Colardyn; D L Clement
Journal:  Cardiovasc Drugs Ther       Date:  1989-04       Impact factor: 3.727

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.